Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Popat U, Hosing C, Saliba RM, Anderlini P, van Besien K, Przepiorka D, Khouri IF, Gajewski J, Claxton D, Giralt S, Rodriguez M, Romaguera J, Hagemeister F, Ha C, Cox J, Cabanillas F, Andersson BS, Champlin RE.
Popat U, et al. Among authors: khouri if.
Bone Marrow Transplant. 2004 May;33(10):1015-23. doi: 10.1038/sj.bmt.1704483.
Bone Marrow Transplant. 2004.
PMID: 15048145